Assignee
H LUNDBECK AS
DK·208 granted patents·77 pending applications·671 citations·filing 2003–2025
Top patents by PatentIndex Score
285 records- 0198US11707476B2Catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 0298US11542323B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Jan 3, 2023·6 cites·24 claims
- 0398US11524995B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Dec 13, 2022·6 cites·20 claims
- 0498US11110110B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·20 claims
- 0598US11104697B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Aug 31, 2021·14 cites·12 claims
- 0697US12226428B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2023·Granted Feb 18, 2025·6 cites·22 claims
- 0797US11938185B2Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 26, 2024·3 cites·42 claims
- 0897US11827665B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Nov 28, 2023·8 cites·21 claims
- 0997US11421024B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Aug 23, 2022·6 cites·23 claims
- 1097US11026923B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·17 claims
- 1197US11026924B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·19 claims
- 1297US10800836B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2016·Granted Oct 13, 2020·10 cites·10 claims
- 1397US10729710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2018·Granted Aug 4, 2020·21 cites·15 claims
- 1497US10647764B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 1597US10647763B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 1697US10640554B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 5, 2020·9 cites·14 claims
- 1796US11866410B2Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diolH LUNDBECK AS·Filed 2021·Granted Jan 9, 2024·8 cites·18 claims
- 1896US11858954B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Jan 2, 2024·8 cites·31 claims
- 1996US11851456B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Dec 26, 2023·9 cites·23 claims
- 2096US11639380B2Acute treatment and rapid treatment of headache using anti-CGRP antibodiesH LUNDBECK AS·Filed 2020·Granted May 2, 2023·11 cites·11 claims
- 2196US11168056B2Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diolH LUNDBECK AS·Filed 2020·Granted Nov 9, 2021·14 cites·13 claims
- 2296US11130775B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 28, 2021·14 cites·16 claims
- 2396US11111263B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·18 claims
- 2496US10364285B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 30, 2019·13 cites·9 claims
- 2596US10358484B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 2696US10358483B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 2796US10351561B2Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 16, 2019·12 cites·21 claims
- 2895US12162936B2Methods of treatment with anti-PACAP antibodiesH LUNDBECK AS·Filed 2021·Granted Dec 10, 2024·2 cites·23 claims
- 2995US11993648B2Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversionH LUNDBECK AS·Filed 2020·Granted May 28, 2024·3 cites·9 claims
- 3095US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 3195US10975135B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 13, 2021·4 cites·34 claims
- 3295US10968268B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 6, 2021·4 cites·34 claims
- 3395US10954285B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 23, 2021·4 cites·34 claims
- 3495US10806718B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Oct 20, 2020·7 cites·16 claims
- 3595US10358482B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·11 cites·9 claims
- 3695US10196439B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2016·Granted Feb 5, 2019·23 cites·20 claims
- 3794US12077578B2Compositions and methods for treating synucleinopathiesH LUNDBECK AS·Filed 2023·Granted Sep 3, 2024·5 cites·16 claims
- 3894US10934348B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Mar 2, 2021·6 cites·11 claims
- 3994US10034861B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 31, 2018·13 cites·28 claims
- 4093US11548849B2Alcohol derivatives as KV7 potassium channel openersH LUNDBECK AS·Filed 2020·Granted Jan 10, 2023·3 cites·9 claims
- 4193US11491140B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Nov 8, 2022·2 cites·20 claims
- 4293US11434199B2Alcohol derivatives as KV7 potassium channel openersH LUNDBECK AS·Filed 2020·Granted Sep 6, 2022·4 cites·12 claims
- 4393US11434222B2MAGL inhibitorsH LUNDBECK AS·Filed 2021·Granted Sep 6, 2022·2 cites·12 claims
- 4493US10689379B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Jun 23, 2020·6 cites·14 claims
- 4593US10618913B2Macrocycles as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Apr 14, 2020·7 cites·19 claims
- 4693US10512632B21 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 24, 2019·9 cites·13 claims
- 4792US10889635B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jan 12, 2021·6 cites·20 claims
- 4892US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 4992US10479835B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Nov 19, 2019·4 cites·16 claims
- 5092US10428147B2Anti-sortilin antibodies, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Oct 1, 2019·4 cites·7 claims
Showing the top 50 of 285 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when H LUNDBECK AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →